Position in VTRS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$226,894,274
+$36,012,612 QoQ
Shares Held
14,288,053
+1.1% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#15
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
This page
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,894,274 | 14,288,053 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $190,881,662 | 14,128,917 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $171,193,705 | 13,750,499 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $123,364,208 | 12,461,032 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $92,064,620 | 10,309,589 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $90,891,176 | 10,435,268 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $133,811,808 | 10,747,937 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $129,097,807 | 11,119,536 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $122,416,369 | 11,516,122 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $137,179,643 | 11,489,083 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $127,580,458 | 11,780,283 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $115,567,968 | 11,720,890 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $121,336,274 | 12,157,944 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $121,610,762 | 12,641,452 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $140,042,929 | 12,582,474 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $80,721,166 | 9,474,316 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $119,305,107 | 11,394,949 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $120,384,537 | 11,064,756 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $196,500,241 | 14,523,300 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $219,135,038 | 16,172,328 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $233,324,457 | 16,327,814 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $161,085,942 | 11,530,848 | Shares | Other | 2021-05-13 | |
| 2020-12-31 | $206,152,832 | 11,000,685 | Shares | Other | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||